Philips Digital Pathology Solution Receives CE Mark for Diagnosis to Help Advance Oncology Diagnosis

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) has acquired the CE mark for diagnostic use of its Philips Digital Pathology Solution. European pathologists will now be able to use the full digital solution as an aid in diagnosis for routine pathology, such as primary diagnosis of oncology.

With the aging population and the increasing knowledge of the complexity of cancer cases, improving the efficiency and quality of cancer diagnostics has become a critical concern. By digitizing the images pathologists normally view through a microscope, Philips' solution offers high-quality images that could enable a more objective and quantitative diagnosis than currently possible. These digital images could also enable new ways to mine information from tumor tissue for further data analysis. Additionally, enhanced collaboration capabilities may speed up consults and second opinions which could improve diagnostic confidence.

"Pathologists play a critical role in the increasing demand for cancer diagnosis and care, and digital pathology looks promising in its ability to support faster, more confident diagnosis," said Perry van Rijsingen, General Manager of Philips Digital Pathology Solutions. "Helping improve workflows and collaboration could increase efficiency and productivity, and we believe that digitization will arm pathologists with the resources they need to successfully improve diagnostics."

The CE mark includes diagnosis for routine pathology including Hematoxylin and Eosin (H&E), Immunohistochemistry (IHC) and special stained tissue sections.

Through the Digital Pathology Solution, Philips strives to enable a faster and simplified pathology workflow and improved outcomes to make pathology labs more efficient. The digitization of pathology workflow is expected to ease logistical burdens and enables new ways of working, such as real-time collaboration between pathologists, the creation of virtual networks and the use of dedicated software tools.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 113,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...